The companies tout the collaboration as the first of its kind. They will combine their interventional cardiology portfolios to provide a comprehensive offering ranging from diagnostic to percutaneous coronary intervention (PCI) to cardiac care centers in the region.
Boston Scientific’s medical devices and capabilities will be paired with GE Healthcare’s medical imaging systems, including its cardiac catheterization lab and related software, to support diagnosis, treatment and monitoring across cardiac care, according to a news release.
“Bridging the industry gap in providing an end-to-end cardiac care center for healthcare providers, this partnership will see the integration of cardiac care solutions, from cath labs to intravascular ultrasound (IVUS), serving as a comprehensive portfolio for heart surgeons,” GE Healthcare (ASEAN region) President & CEO Chris Khang said in the release. “These solutions will be crucial in unlocking the potential of interventional cardiology and is a step forward in delivering precision health to the region.”
Boston Scientific VP & Managing Director for Korea and ASEAN added that the collaboration “can ensure treatment of patients of all degrees of complexity is readily available.”